iBio Share Price
NASDAQ: IBIO | HealthcareiBio Stock Performance
iBio Share Price Chart
iBio Quarterly Profit & Loss
All figures in USD
iBio Annual Profit & Loss
All figures in USD
iBio Balance Sheet
All figures in USD Million
iBio Cash Flow
All figures in USD Million
Corporate Actions
About iBio
iBio Inc is a clinical-stage biotechnology company using Artificial Intelligence (AI) for the development of hard-to-drug precision antibodies for obesity, cardiometabolic, and cardiopulmonary diseases. Its product candidate pipeline includes IBIO-610, a monoclonal antibody designed to block Activin E; IBIO-800, a bispecific antibody program targeting myostatin, growth differentiation factor 11 (GDF11), and Activin A; IBIO-600; Amylin Antibody; and Target 4, in different stages of development, being developed as potential therapies for obesity and cardiometabolic disease. The company operates as one reportable segment, which is that of a biotechnology company leveraging AI and ML for the development of hard-to-drug precision antibodies.
iBio Historical Returns
| Month | Open | Close | Change % |
|---|